ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Smoking"

  • Abstract Number: 0680 • ACR Convergence 2022

    Association of Environmental Risk Factors with Antiphospholipid Antibodies and Thrombosis in 1199 International Patients Referred for Suspected Antiphospholipid Syndrome

    Medha Barbhaiya1, Deanna Jannat-Khah, DrPH, MSPH1, Jonah Levine1, Karen Costenbader2 and Doruk Erkan1, 1Hospital for Special Surgery, New York, NY, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Whether environmental risk factors induce antiphospholipid antibody (aPL) positivity and increase the risk of arterial thrombosis (AT) and venous thromboembolism (VTE) in aPL-positive patients…
  • Abstract Number: 0698 • ACR Convergence 2022

    Cohort Study of Cigarette Smoking and the Risk of Developing Polymyalgia Rheumatica Among Women

    Jae Hee Kang1, Susan Malspeis2, Nicole Yang2 and Karen Costenbader2, 1Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease among older White women, but little is known of its etiology and there are…
  • Abstract Number: 0941 • ACR Convergence 2022

    Surveying Adolescents with Rheumatic Disease for At-Risk Behavior

    Kristina Ciaglia1, Chetna Godiwala2, Chan-hee Jo2, Tracey Wright3, Lynnette Walters2 and Lorien Nassi1, 1University of Texas Southwestern, Dallas, TX, 2Scottish Rite Hospital for Children, Dallas, TX, 3UT Southwestern, Plano, TX

    Background/Purpose: Adolescents with rheumatic disease are often prescribed teratogenic medications, however few rheumatologists screen patients for sexual activity and provide referrals or contraceptive education due…
  • Abstract Number: 1032 • ACR Convergence 2022

    Anti-arthritogenic Effect of Smoking in Curdlan-Administered SKG Mice

    YoungEun Kim1, Eun-Ju Lee1, Jae-Hyun Lee1, Soo Min Ahn1, Ji Seon Oh2, Seokchan Hong1, Chang Keun Lee1, Bin Yoo1 and Yong Gil Kim1, 1Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, Seoul, Republic of Korea, 2Department of Information Medicine, Big Data Research Center, Asan Medical Center, Seoul, Republic of Korea

    Background/Purpose: Alpha7 nicotinic acetylcholine receptor (α7nAChR), a member of AChR expressed in various immune cells and synoviocytes, has an important role in the anti-inflammatory pathway…
  • Abstract Number: 1036 • ACR Convergence 2022

    Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by History of Cigarette Smoking

    Alexis Ogdie1, Lars Erik Kristensen2, Enrique R Soriano3, Servet Akar4, Yanhui Sun5, David Gruben6, Lara Fallon7, Cassandra D Kinch8 and Dafna Gladman9, 1Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2The Parker Institute, Copenhagen University Hospital, Copenhagen, Denmark, 3Rheumatology Unit and University Institute, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Izmir Katip Celebi University School of Medicine, Izmir, Turkey, 5Pfizer CRDC, Shanghai, China, 6Pfizer Inc, Groton, CT, 7Pfizer Inc, Montréal, QC, Canada, 8Pfizer Canada ULC, Kirkland, Canada, 9Toronto Western Hospital, Schroeder Arthritis Institute, Toronto, ON, Canada

    Background/Purpose: In patients (pts) with PsA and AS, smoking may be associated with an increased comorbidity burden, and greater responses to TNF inhibitors (TNFi) are…
  • Abstract Number: 1196 • ACR Convergence 2022

    Interaction of Cumulative Inflammation with Smoking and Lipids in Risk Modification of Dementia Among Patients with Rheumatoid Arthritis: A Population-based Cohort Study

    Chanakya Kodishala1, Stephanie Duong2, Cassondra Hulshizer2, Ryan Lennon2, Rabia Javed2, Maria Vassilaki2, Michelle Mielke3, John Davis2, Cynthia Crowson4 and Elena Myasoedova2, 1Mayo Clinic Rochester Minnesota, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Wake Forest University School of Medicine, Winston-Salem, NC, 4Mayo Clinic, Eyota, MN

    Background/Purpose: Patients with rheumatoid arthritis (RA) have increased risk of developing dementia. Systemic inflammation is implicated in the pathogenesis of cognitive decline. However, the association…
  • Abstract Number: 1317 • ACR Convergence 2022

    The Epidemiology of Old versus Young Males Referred for BMD Assessment

    Muhammed Aqib Khan1, Rabie Hamad1, Hamzah Amin1 and Marwan Bukhari2, 1Royal Lancaster Infirmary, Lancaster, United Kingdom, 2University Hospitals of Morecambe Bay NHS Trust, Lancaster, United Kingdom

    Background/Purpose: Data on osteoporosis in men are scarce. The World Health Organisation's (WHO) definition of a T-score less than 2.5 has only been described for…
  • Abstract Number: 1510 • ACR Convergence 2022

    Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis – Data from 14 European Countries

    Gareth Jones1, Ovidiu Rotariu1, Brigitte Michelsen2, Bente Glintborg3, Bjorn Gudbjornsson4, Arni Geirsson5, Heikki Relas6, Pia Isomäki7, Jakub Závada8, Karel Pavelka9, Ziga Rotar10, Matija Tomsic10, Michael Nissen11, Adrian Ciurea12, Catalin Codreanu13, Johan Karlsson Wallman14, Eirik Kristianslund15, Simon Rasmussen16, Lykke Ørnbjerg17, Maria José Santos18, Mikkel Østergaard19, Merete L Hetland20 and Gary Macfarlane1, 1University of Aberdeen, Aberdeen, Scotland, United Kingdom, 2Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, Kristiansand, Norway, 3Rigshospitalet, Glostrup, Virum, Denmark, 4Centre for Rheumatology Research, University Hospital, Reykjavik, Iceland, 5Department of Rheumatology, Landspitali University Hospital, Reykjavik, Iceland, 6Rheumatology, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland, 7Centre for Rheumatology, Tampere University Hospital, Tampere, Finland, 8Institute of Rheumatology, Prague, Czech Republic, 9Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Praha, Czech Republic, 10University Medical Centre Ljubljana, Ljubljana, Slovenia, 11Hopitaux Universitaires de Genève, Geneva, Switzerland, 12University Hospital Zurich, Zürich, Switzerland, 13Center for Rheumatic Diseases, Bucharest, Romania, 14Lund University and Skane University Hospital, Hjarup, Sweden, 15Diakonhjemmet Hospital, Division of Rheumatology and Research, Oslo, Norway, 16Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark, 17Copenhagen Center for Arthritis Research, Glostrup, Denmark, 18Hospital Garcia de Orta, Almada, Charneca da Caparica, Portugal, 19Rigshospitalet, University of Copenhagen, Glostrup, Denmark, 20Rigshospitalet, Glostrup, Denmark

    Background/Purpose: In axial spondyloarthritis (axSpA) much attention has been focused on pharmacological management, including tumour necrosis factor inhibitors (TNFi), as a means to reducing inflammation,…
  • Abstract Number: 1576 • ACR Convergence 2022

    Clinical Presentation and Outcome of Patients with Chronic Abdominal Periaortitis

    Umar Ghaffar1, Hannah Langenfeld2, Cynthia Crowson3, Tanaz Kermani4, Michelle Burke1, Boyd Viers1, Aaron Potretzke1, Haraldur Bjarnason1, Kenneth J. Warrington1 and Matthew J. Koster1, 1Mayo Clinic, Rochester, MN, 2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 3Mayo Clinic, Eyota, MN, 4University of California Los Angeles, West Hills, CA

    Background/Purpose: To evaluate the presentation features and outcomes of patients with chronic abdominal periaortitis in a large referral cohort. Methods: Using a proprietary medical text…
  • Abstract Number: 2248 • ACR Convergence 2022

    Prevalence and Mortality of Interstitial Lung Abnormalities in Rheumatoid Arthritis and non-RA Comparators in a Multicenter Prospective Cohort

    Gregory McDermott1, Keigo Hayashi2, Kazuki Yoshida1, Matthew Moll1, Michael Cho1, Tracy Doyle1, Paul Dellaripa1, Rachel Putman1, Raul San Jose Estepar1, George Washko1, Elizabeth Regan3, Hiroto Hatabu1, Gary M Hunninghake1, Edwin Silverman1 and Jeffrey Sparks4, 1Brigham and Women's Hospital, Boston, MA, 2Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 3National Jewish Health, Denver, CO, 4Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Subpleural interstitial lung abnormalities (ILA) may be a form of subclinical or preclinical interstitial lung disease (ILD) and have been reported in up to…
  • Abstract Number: 1797 • ACR Convergence 2021

    Are Smoking and Alcohol Associated with Peripheral Musculoskeletal Involvement in Patients with Spondyloarthritis? Results from the ASAS-PerSpA Study

    M.Lourdes Ladehesa-Pineda1, Rafaela Ortega2, Mara ngeles Puche Larrubia1, Maxime Dougados3, Eduardo Collantes-Estevez2 and Clementina López Medina4, 1Hospital Universitario Reina Sofía, Córdoba, Spain, 2IMIBIC/Reina Sofia Hospital/University of Córdoba, Córdoba, Spain, 3Université de Paris . Department of Rheumatology - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris . INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité. Paris, France., Paris, France, 4Department of Rheumatology, Reina Sofia Hospital, IMIBIC, University of Cordoba, Cordoba, Spain/ Department of Rheumatology, University of Paris, Cochin Hospital, Paris, France

    Background/Purpose: There are controversies around the role of smoking in manifestations of axial spondyloarthritis (axSpA) such as peripheral involvement. It has been observed an inverse…
  • Abstract Number: 0017 • ACR Convergence 2021

    Lessons Learnt from Associations Between Anti-modified Protein Antibodies and Risk Factors: Human Leukocyte Antigen – Shared Epitope Alleles Solely Associate with Anti-citrullinated Protein Antibodies

    Tineke J van wesemael, Annemarie L. Dorjee, Tom WJ Huizinga, Annette H.M van der Helm-van Mil, René Toes and Diane van der Woude, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by the presence of auto-antibodies to post translationally modified proteins (anti-modified protein antibodies (AMPA)): anti-citrullinated protein antibodies (ACPA), anti-carbamylated…
  • Abstract Number: 0082 • ACR Convergence 2021

    Association of Current Cigarette Smoking and Obesity with Antiphospholipid Antibodies and Thrombosis in 1216 International Patients Evaluated for Suspected Antiphospholipid Syndrome (APS)

    Medha Barbhaiya1, Deanna Jannat-Khah1, Doruk Erkan1, Karen Costenbader2 and On Behalf of New APS Classification Criteria Development Case Collectors1, 1Hospital for Special Surgery, New York, NY, 2Brigham and Women's Hospital, Belmont, MA

    Background/Purpose: Few studies have evaluated the role of environmental factors in APS. While antiphospholipid antibodies (aPL) may be induced by environmental stiumuli, e.g., viruses, cardiovascular…
  • Abstract Number: 0564 • ACR Convergence 2021

    Associations of Sinusitis, Pharyngitis, and Respiratory Tract Disease Burden with Incident Rheumatoid Arthritis

    Vanessa Kronzer1, Weixing Huang2, Alessandra Zaccardelli2, Cynthia Crowson3, John Davis1, Robert Vassallo1, Tracy Doyle4, Elena Losina2 and Jeffrey Sparks2, 1Mayo Clinic, Rochester, MN, 2Brigham and Women's Hospital, Boston, MA, 3Mayo Clinic, Eyota, MN, 4Brigham and Women's Hospital, West Roxbury, MA

    Background/Purpose: Increasing evidence implicates respiratory mucosa in the pathogenesis of rheumatoid arthritis (RA). However, individual respiratory tract diseases, especially of the upper airways, sinuses, and…
  • Abstract Number: 0641 • ACR Convergence 2021

    Title: EHR-Supported Staff Protocol Improves Smoking Cessation in a Diverse Rheumatology Clinic: Updated Results of Quit Connect Dissemination

    Jennifer Brandt1, Edmond Ramly2, Monica Messina3, S Sam Lim4 and Christie Bartels3, 1Emory School of Medicine, Atlanta, GA, 2University of Wisconsin School of Medicine, Madison, WI, 3University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Smoking is a risk factor for rheumatologic conditions like lupus and rheumatoid arthritis and predicts worse outcomes. Smoking and rheumatic disease increase risk for…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology